MedPath

The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir

Not Applicable
Completed
Conditions
HIV Infections
Registration Number
NCT00000898
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

The purpose of this study is to see if staggering doses of nelfinavir, ritonavir, and saquinavir has any effect on the interactions between these drugs.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

Univ of California/ San Francisco / Dept of Medicine

🇺🇸

San Francisco, California, United States

Stanford Univ Med Ctr

🇺🇸

Stanford, California, United States

San Francisco Gen Hosp

🇺🇸

San Francisco, California, United States

Johns Hopkins Hosp

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath